Effects of anti-CTLA-4 antibody on the number and types of T cells present in patient's blood was investigated using LymphoSIGHT immune repertoire sequencing platform, from Sequenta, Inc., as the company announced publication of a study done in collaboration with researchers from UCSF and UCLA. The results, which appear in the May 28 issue of iScience Translational Medicine/i, shed light on the mechanism of action of this type of cancer immunotherapy and suggest that immune ...
Read More
You have just read an article categorized health
titled Anti-CTLA-4 Cancer Immunotherapy Outcome Predicted With T Cell Repertoire Changes.
Written by:
editor -
Thursday, May 29, 2014
There are currently no comments for "Anti-CTLA-4 Cancer Immunotherapy Outcome Predicted With T Cell Repertoire Changes"
Post a Comment